サマリー

エピジェネティクスは、DNA配列の変化を伴わない遺伝的な表現型の変化を研究する学問です。
エピジェネティックデバイスの世界市場は、技術の進歩によって牽引されると予想されます。市場の主要なドライバーは、がんの症例数の増加、高齢化社会の進展、肥満人口の増加です。
最新の調査によると、世界のエピジェネティック市場規模は2028年に11億5000万米ドルに達し、分析期間中に7.4%のCAGRで成長すると予想されています。

グローバルエピジェネティックの範囲と市場規模
本レポートでは、世界のエピジェネティックな状況、将来予測、成長機会、主要市場、主要プレイヤーに焦点を当てています。研究の目的は、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東＆アフリカなどにおけるEpigeneticの発展を提示することです。

種類別セグメント
試薬
キット
機器
酵素
サービス
用途別セグメント
学術研究機関
バイオテクノロジー企業
バイオ製薬会社
診断薬メーカー

地域別
北米
ヨーロッパ
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

会社別
イルミナ
キアゲン
アブカム
メルク・アンド・カンパニー
シグマ・アルドリッチ
ニューイングランド・バイオラボ
サーモフィッシャーサイエンティフィック
ダイアジェノード
アクティブモティーフ
ロシュ・ダイアグノスティックス
エーザイ
ノバルティス

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetic Market Size Growth Rate by Type (2022-2028)
1.2.2 Reagents
1.2.3 Kits
1.2.4 Instruments
1.2.5 Enzymes
1.2.6 Services
1.3 Market by Application
1.3.1 Global Epigenetic Market Share by Application (2022-2028)
1.3.2 Academic Research Institutes
1.3.3 Biotechnology Companies
1.3.4 Biopharmaceutical Companies
1.3.5 Diagnostic Companies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Epigenetic Market Size
2.2 Epigenetic Market Size by Regions
2.2.1 Epigenetic Growth Rate by Regions (2022-2028)
2.2.2 Epigenetic Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Epigenetic Revenue by Players (2022 & 2028)
3.2 Epigenetic Key Players Headquarters and Area Served
3.3 Key Players Epigenetic Product/Solution/Service
3.4 Date of Enter into Epigenetic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Epigenetic Market Size by Type (2022-2028)
4.2 Global Epigenetic Market Size by Application (2022-2028)
5 North America
5.1 North America Epigenetic Market Forecast (2022-2028)
5.2 Epigenetic Key Players in North America
5.3 North America Epigenetic Market Size by Type
5.4 North America Epigenetic Market Size by Application
6 Europe
6.1 Europe Epigenetic Market Forecast (2022-2028)
6.2 Epigenetic Key Players in Europe
6.3 Europe Epigenetic Market Size by Type
6.4 Europe Epigenetic Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Epigenetic Market Forecast (2022-2028)
7.2 Epigenetic Key Players in Asia-Pacific
7.3 Asia-Pacific Epigenetic Market Size by Type
7.4 Asia-Pacific Epigenetic Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Epigenetic Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Epigenetic Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Illumina
9.1.1 Illumina Company Details
9.1.2 Illumina Description and Business Overview
9.1.3 Illumina Epigenetic Introduction
9.1.4 Illumina Revenue in Epigenetic Business (2022 & 2028)
9.1.5 Illumina Recent Development
9.2 Qiagen
9.2.1 Qiagen Company Details
9.2.2 Qiagen Description and Business Overview
9.2.3 Qiagen Epigenetic Introduction
9.2.4 Qiagen Revenue in Epigenetic Business (2022 & 2028)
9.2.5 Qiagen Recent Development
9.3 Abcam
9.3.1 Abcam Company Details
9.3.2 Abcam Description and Business Overview
9.3.3 Abcam Epigenetic Introduction
9.3.4 Abcam Revenue in Epigenetic Business (2022 & 2028)
9.3.5 Abcam Recent Development
9.4 Merck & Co
9.4.1 Merck & Co Company Details
9.4.2 Merck & Co Description and Business Overview
9.4.3 Merck & Co Epigenetic Introduction
9.4.4 Merck & Co Revenue in Epigenetic Business (2022 & 2028)
9.4.5 Merck & Co Recent Development
9.5 Sigma-Aldrich
9.5.1 Sigma-Aldrich Company Details
9.5.2 Sigma-Aldrich Description and Business Overview
9.5.3 Sigma-Aldrich Epigenetic Introduction
9.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2022 & 2028)
9.5.5 Sigma-Aldrich Recent Development
9.6 New England Biolabs
9.6.1 New England Biolabs Company Details
9.6.2 New England Biolabs Description and Business Overview
9.6.3 New England Biolabs Epigenetic Introduction
9.6.4 New England Biolabs Revenue in Epigenetic Business (2022 & 2028)
9.6.5 New England Biolabs Recent Development
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Company Details
9.7.2 Thermo Fisher Scientific Description and Business Overview
9.7.3 Thermo Fisher Scientific Epigenetic Introduction
9.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2022 & 2028)
9.7.5 Thermo Fisher Scientific Recent Development
9.8 Diagenode
9.8.1 Diagenode Company Details
9.8.2 Diagenode Description and Business Overview
9.8.3 Diagenode Epigenetic Introduction
9.8.4 Diagenode Revenue in Epigenetic Business (2022 & 2028)
9.8.5 Diagenode Recent Development
9.9 Active Motif
9.9.1 Active Motif Company Details
9.9.2 Active Motif Description and Business Overview
9.9.3 Active Motif Epigenetic Introduction
9.9.4 Active Motif Revenue in Epigenetic Business (2022 & 2028)
9.9.5 Active Motif Recent Development
9.10 Roche Diagnostics
9.10.1 Roche Diagnostics Company Details
9.10.2 Roche Diagnostics Description and Business Overview
9.10.3 Roche Diagnostics Epigenetic Introduction
9.10.4 Roche Diagnostics Revenue in Epigenetic Business (2022 & 2028)
9.10.5 Roche Diagnostics Recent Development
9.11 Eisai
9.11.1 Eisai Company Details
9.11.2 Eisai Description and Business Overview
9.11.3 Eisai Epigenetic Introduction
9.11.4 Eisai Revenue in Epigenetic Business (2022 & 2028)
9.11.5 Eisai Recent Development
9.12 Novartis
9.12.1 Novartis Company Details
9.12.2 Novartis Description and Business Overview
9.12.3 Novartis Epigenetic Introduction
9.12.4 Novartis Revenue in Epigenetic Business (2022 & 2028)
9.12.5 Novartis Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details